Zeus Expands Portfolio with New Polyimide Family of Products

Food and Healthcare Press Releases Wednesday June 12, 2019 08:36
ORANGEBURG, South Carolina--12 Jun--PRNewswire/InfoQuest
Products Include PI Tubing, PI Coated Wire, PI Glide(TM) Tubing, and PI Glide(TM) Coated Wire

Zeus Industrial Products, Inc. (Zeus), a leading polymer solutions provider and material science innovator, has announced the introduction of a new polyimide (PI) family of products. The new additions include tubing and coated wire containing polyimide and PI Glide(TM), a more lubricious composite of polyimide with PTFE.

With the addition of these products to Zeus' established portfolio, medical device manufacturers are able to further consolidate suppliers, benefiting from Zeus' proven quality, service, capability, and capacity to grow.

Design engineers can benefit from polyimide resin's inherent characteristics, as well as the ability to:
  • Minimize profile, maximize the available working channel, and reduce rigidity with thin wall thicknesses.
  • Customize lubricity and strength by layering polyimide and PI Glide(TM).
  • Combine PI Glide(TM) with a polyimide jacket to create tubing with a lubricious ID and a bondable OD.

Zeus is exhibiting its new polyimide product family in booth 1421 at MD&M East, the East Coast's leading MedTech event. MD&M East takes place on June 11th -13th, 2019 at the Jacob K. Javits Convention Center, New York City.

COMMENTS

"When it comes to PI components, device manufacturers look for more from a supplier than quality products at competitive prices. They want a partner who understands their business model, competitive pressures, and time-to-market objectives. As a best-in-class component supplier, Zeus realizes these needs and has the infrastructure in place to meet each customer's current and future requirements." – Daryl Leach, Director of Global Market Management, Zeus Industrial Products, Inc.

"By launching this new PI family of products, Zeus makes it easy for manufacturers to consolidate vendors for their catheter components. Transitioning to our PI products will help manufacturers improve supply continuity, increase yields and throughput, and generate cost savings." – Matt Allen, Global Manager Medical Markets, Zeus Industrial Products, Inc.

QUICK FACTS
  • Zeus introduced a polyimide family offering tubing and coated wire capabilities, with optional PI Glide(TM) for improved lubricity.
  • Customized polyimide and PI Glide(TM) layers bring the best characteristics of each to device designs.
  • Consolidated supplier sourcing leverages Zeus' proven quality, service, capability, and capacity to grow.
RESOURCES
Click here to request free samples [https://vsl.zeusinc.com/?_ga=2.53572840.1999997649.1547681847-454645836.1547681847].
Zeus Industrial Products: Learn more about the company and its products on the Zeus website; or call toll-free 1-800-526-3842 or +1-803-268-9500 outside the U.S.
ABOUT ZEUS INDUSTRIAL PRODUCTS, INC.

Zeus Industrial Products, Inc., is headquartered in Orangeburg, SC, USA. Its core business is the development and precision extrusion of advanced polymeric materials. The company employs over 1,700 people worldwide with sales and manufacturing facilities in Aiken, Gaston, and Orangeburg, South Carolina; Branchburg, New Jersey; Chattanooga, Tennessee; Guangzhou China; and Letterkenny, Ireland. Zeus products and services serve companies in the medical, automotive, aerospace, fiber optics, energy, and fluid management markets. For more information, visit www.zeusinc.com.

Logo - https://mma.prnewswire.com/media/790870/Zeus_Logo.jpg

Latest Press Release

Accor Pattaya Blood Donation #3/2019

On Tuesday 17th, September 2019, Hotel Baraquda Pattaya - MGallery and Mercure Pattaya Hotel attended to Accor Pattaya Blood Donation #3/2019 at Veranda Resort Pattaya Na Jomtien - MGallery, MM Meeting Room. The event started at 10.00 a.m. to 02.00 p.m....

Tresiba(R) Showed an Overall Lower Risk of Hypoglycaemia and Significantly Lower HbA1c When Compared to Insulin Glargine U300 in People With Type 2 Diabetes

According to new data from the CONCLUDE head-to-head trial, Tresiba(R) (insulin degludec) showed an overall lower risk of hypoglycaemia, also known as a hypo or low blood sugar, at a significantly lower HbA1c, compared with insulin glargine U300 in...

BookDoc, partners it#s way to being Southeast Asia#s Next Generation Healthcare Ecosystem is looking to raise Series A from Strategic partners

This year crosses 100 strategic partnerships in over 20 cities across Malaysia, Singapore, Indonesia, Thailand and Hong Kong. Since commenced operations in 2015, BookDoc has grown exponentially with four consecutive years of over 450% annual growth rate...

United Nations Political Declaration on Universal Health Coverage Finally has Some Teeth

FDI World Dental Federation (FDI) welcomes the long overdue commitment to strengthening oral health in the UN Political Declaration on Universal Health Coverage (UHC). The declaration will be officially adopted by world leaders at the UN High-Level...

Ozempic(R) Offers Superior Reductions in HbA1c and Body Weight Compared to Both Victoza(R) and Canagliflozin in People With Type 2 Diabetes

Novo Nordisk announced today the results from two Ozempic(R) (once-weekly semaglutide 1.0 mg) head-to-head Phase 3 clinical trials, SUSTAIN 8 and SUSTAIN 10, which showed: - Ozempic(R) was superior to treatment with the SGLT-2 inhibitor canagliflozin...

Related Topics